Moreover, cGAS-positive micronuclei were also observed after in vivo paclitaxel treatment of human breast cancer patient-derived xenografts (PDX) grown in immunodeficient mice (described in Supplementary Fig. 3a) (Fig. 1d). This evidence concerns the gene CGAS and breast carcinoma.